Genmab | Resultado Líquido



Net Income Alterar Data
Agios Pharmaceuticals USD -89289000 7.23M 2025-03
Almirall EUR -5243000 20.63M 2024-12
Amarin USD -25134000 26.66M 2024-09
Amgen USD 1.73B 1.1B 2025-03
argenx SE USD 169.47M 604.69M 2025-03
AstraZeneca USD 2.92B 1.42B 2025-03
Bayer EUR 1.3B 1.63B 2025-03
BioMarin Pharmaceutical USD 185.69M 60.74M 2025-03
Demant DKK 1.19B 588.5M 2024-12
Exelixis USD 159.62M 19.76M 2025-04
Fresenius Medical Care EUR 151M 84.1M 2025-03
Galapagos EUR -153403000 178.71M 2025-03
Genmab DKK 195M 3.65B 2025-03
GlaxoSmithKline GBP 1.62B 1.21B 2025-03
GN Store Nord DKK 71M 296M 2025-03
GRIFOLS EUR 59.72M 9.24M 2025-03
Hikma Pharmaceutical USD 133M 93M 2024-12
Insmed USD -256583000 21.04M 2025-03
Lonza CHF 307M 22M 2024-12
Merck EUR 735M 68M 2025-03
Novartis USD 2.82B 371M 2024-12
Regeneron Pharmaceuticals USD 808.7M 109M 2025-03
Roche Holding CHF 1.01B 2.12B 2024-12
Sanofi EUR 1.87B 1.37B 2025-03
UCB EUR 857M 649M 2024-12



Genmab Resultado Líquido - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Jun 2025.